This Entry is listed in:
Create an account or login to tag this entry
|
From Crohn's Disease - Living with Crohn's Disease | Posted 7 months, 1 week ago:
The US Food and Drug Administration has approved a new drug for sufferers of Crohn's disease. Certolizumab pegol (Cimzia) received approval for use in adults with moderate to severe Crohn's disease who have not responded to conventional therapies. Th... read more
|
